Finch Therapeutics GroupFNCHQ
13F holders, Q1 2024 (March 31)11holders
$2.62avg. 13F price*
At the end of Q1 2024, 11 institutions reported holding Finch Therapeutics Group Inc. (FNCHQ) in their 13F filings. The largest holders were Susquehanna International Group, LLP ($155K), Vanguard Group Inc. ($94K) and Lake Street Advisors Group, LLC ($56K).
- Company
- Finch Therapeutics Group Inc.
- CUSIP
- 31773D200
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 6 | $286K |
Ownership 11 holders
| Susquehanna International Group, LLP | 0.00% | No change | 59,028 | $155K |
| Vanguard Group Inc. | 0.00% | Reduce -6.5% | 36,252 | $94K |
| Lake Street Advisors Group, LLC | 0.00% | No change | 21,206 | $56K |
| Ikarian Capital, LLC | 0.00% | No change | 6,892 | $18K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +58.5% | 4,163 | $11K |
| Bleichroeder LP | 0.00% | No change | 971 | $3K |
| BlackRock Inc. | 0.00% | Reduce -4.1% | 327 | $850 |
| Morgan Stanley | 0.00% | Add +26.8% | 156 | $406 |
| UBS Group AG | 0.00% | Add +5400.0% | 110 | $286 |
| Wells Fargo & Company | 0.00% | Add +16.7% | 7 | $18 |
| Royal Bank of Canada | 0.00% | No change | 27 | $0 |
"% of holder's portfolio" is FNCHQ's weight in each manager's 13F, not the share of Finch Therapeutics Group Inc. the manager owns.